Target
Fatty acid 2-hydroxylase
Ligand
BDBM483714
Substrate
n/a
Meas. Tech.
In Vitro Competitive Activity-Based Protein Profiling
IC50
<100±n/a nM
Citation
 Grice, CAWiener, JJWeber, ODDuncan, KK Pyrazole MAGL inhibitors US Patent  US10927105 Publication Date 2/23/2021 
Target
Name:
Fatty acid 2-hydroxylase
Synonyms:
FA2H | FA2H_HUMAN | FAAH | FAXDC1 | Fatty acid alpha-hydroxylase | Fatty acid hydroxylase domain-containing protein 1
Type:
Protein
Mol. Mass.:
42806.38
Organism:
Human
Description:
Q7L5A8
Residue:
372
Sequence:
MAPAPPPAASFSPSEVQRRLAAGACWVRRGARLYDLSSFVRHHPGGEQLLRARAGQDISADLDGPPHRHSANARRWLEQYYVGELRGEQQGSMENEPVALEETQKTDPAMEPRFKVVDWDKDLVDWRKPLLWQVGHLGEKYDEWVHQPVTRPIRLFHSDLIEGLSKTVWYSVPIIWVPLVLYLSWSYYRTFAQGNVRLFTSFTTEYTVAVPKSMFPGLFMLGTFLWSLIEYLIHRFLFHMKPPSDSYYLIMLHFVMHGQHHKAPFDGSRLVFPPVPASLVIGVFYLCMQLILPEAVGGTVFAGGLLGYVLYDMTHYYLHFGSPHKGSYLYSLKAHHVKHHFAHQKSGFGISTKLWDYCFHTLTPEKPHLKTQ
  
Inhibitor
Name:
BDBM483714
Synonyms:
1-(2-(3-chloro-5- (trifluoromethyl)- benzyl)-2,8- diazaspiro[4.5]- decane-8-carbonyl)-1H- pyrazole-3- carboxamide | US10927105, Ex 196 | US11655217, Example 196
Type:
Small organic molecule
Emp. Form.:
C21H23ClF3N5O2
Mol. Mass.:
469.888
SMILES:
NC(=O)c1ccn(n1)C(=O)N1CCC2(CCN(Cc3cc(Cl)cc(c3)C(F)(F)F)C2)CC1
Structure:
Search PDB for entries with ligand similarity: